Subscribe To
Why you should add humana (hum) stock to your portfolio now
Humana's (HUM) strength in Individual medicare Advantage business and state-based contract wins are lik...
July 10, 2023, 12:30 pm
Biogen and alzheimer's disease: too early to celebrate
The FDA has granted full approval to Biogen and Eisai's anti-amyloid antibody drug Leqembi, but there is skepticism about its efficacy and safety. The...
July 9, 2023, 11:52 pm
medicare will pay for alzheimer's drug leqembi. what patients and doctors should know
Patients with early Alzheimer's disease could still pay more than $5,000 in out-of-pocket costs for Leqembi even with ...
July 8, 2023, 7:00 am
Castle biosciences stock soars on medicare reversal; data presentation
Castle Biosciences, Inc shares surged 55% to $20.64 on Friday after Novitas, a regional medicare admini...
July 7, 2023, 3:24 pm
Sales of alzheimer's drug leqembi may be slow initially but could pick up in 2024
Analysts believe the medicare registry requirement and new guidance on Leqembi's prescription label cou...
July 7, 2023, 1:59 pm
Why castle biosciences stock is crushing it today
Novitas is withdrawing a draft policy that would have denied coverage for Castle's cancer tests. It must still wait on a new draft policy from the reg...
July 7, 2023, 12:16 pm
Will watershed moment for alzheimer's propel biogen stock higher?
Esai and Biogen's Alzheimer's Disease therapeutic, Leqembi, received full FDA approval on July 6th. Full approval likely means at least $100s millions...
July 7, 2023, 10:20 am
Fda approves leqembi, extending alzheimer's treatment to more patients
medicare enrollees can get the anti-amyloid treatment as a result of the agency's full approval....
July 6, 2023, 6:57 pm
Fda approves biogen and eisai alzheimer's treatment leqembi
The U.S. Food and Drug Administration on Thursday granted full approval to the Biogen BIIB and Eisai Co. Ltd. ESALF Alzheimer's treatment Leqembi, a s...
July 6, 2023, 4:55 pm
Fda approves alzheimer's drug leqembi, paving way for broader medicare coverage
Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding....
July 6, 2023, 4:44 pm
Alignment health plan adds tucson medical center to expand access to care for southern arizona seniors
Top hospital in Tucson joins medicare Advantage company’s provider network, elevating senior care for...
July 5, 2023, 3:00 pm
Myomo's (myo) myopro seeks cms classification for medicare cover
If this rule is finalized without any changes to reimbursement practices, Myomo's (MYO) MyoPro could be reimbursed in a lump-sum manner by CMS....
July 5, 2023, 12:17 pm
Molina healthcare acquisition of bright health assets ‘significant' for achieving premium target: broker
Molina Healthcare, Inc. (NYSE:MOH)'s acquisition of Bright Health assets is a positive for the company according to analysts at UBS, who said the deal...
July 4, 2023, 11:04 am
Molina (moh) to buy bright health's california medicare business
Molina's (MOH) Brand New Day and Central Health Plan of California buyout complements Molina's Medicaid footprint and aligns with its 2024 Medi-Cal pl...
July 3, 2023, 1:43 pm
Molina healthcare announces a $600 million deal with bright health
Molina Healthcare Inc (NYSE: MOH) is buying the California medicare Advantage business from Bright Heal...
July 2, 2023, 2:57 pm
Rewalk robotics applauds medicare proposal to include personal exoskeletons in a medicare benefit category to be paid on a lump sum basis
Proposed benefit category assignment represents a positive step in facilitating medicare coverage of pe...
June 30, 2023, 8:58 pm
Molina healthcare to buy bright health group's california medicare business
Molina Healthcare Inc. MOH, +1.98% on Friday announced a deal to buy Bright Health Group Inc.'s BHG, -1.00% California ...
June 30, 2023, 8:42 am
Scpharmaceuticals: oversold territory, drug launch still looks robust
scPharmaceuticals' Furoscix dose-filling rates increased by 55% month over month in May. Despite the lower figures than market expectations, SCPH stoc...
June 29, 2023, 11:05 pm
Cigna: buy while it's still cheap and not loved
The Cigna Group investors who picked the May lows have benefited from its recovery. The selloff triggered by concerns over ...
June 29, 2023, 5:28 pm
medicare coverage of weight-loss drugs? don't count on it, analysts say.
Investors should not bank on medicare covering the powerful new weight-loss drugs from Eli Lilly & Co. ...
June 29, 2023, 8:32 am